Terns Pharmaceuticals, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| SOLEUS CAPITAL MANAGEMENT, L.P. | 11/14/2025 | 8.13 M | $61.03 M | -0.49% | 8.87% |
| MORGAN STANLEY | 11/14/2025 | 7.59 M | $56.99 M | 4.63% | 8.29% |
| ORBIMED ADVISORS LLC | 11/14/2025 | 7.56 M | $56.80 M | 0.00% | 8.26% |
| DEEP TRACK CAPITAL, LP | 11/14/2025 | 7.50 M | $56.29 M | 0.00% | 8.18% |
| VIVO CAPITAL, LLC | 11/14/2025 | 6.90 M | $51.79 M | 0.00% | 7.53% |
| COMMODORE CAPITAL LP | 11/14/2025 | 5.70 M | $42.81 M | 100.00% | 6.22% |
| BLACKROCK, INC. | 11/12/2025 | 5.55 M | $41.69 M | 1.48% | 6.06% |
| VANGUARD GROUP INC | 11/07/2025 | 4.56 M | $34.24 M | 5.89% | 4.98% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 11/14/2025 | 3.94 M | $29.58 M | 207.73% | 4.30% |
| CANDRIAM S.C.A. | 11/06/2025 | 2.37 M | $17.79 M | 0.00% | 2.59% |
| ACORN CAPITAL ADVISORS, LLC | 11/17/2025 | 1.97 M | $14.80 M | 0.00% | 2.15% |
| SCHONFELD STRATEGIC ADVISORS LLC | 11/14/2025 | 1.89 M | $14.21 M | -37.97% | 2.07% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2025 | 1.71 M | $12.88 M | 4.97% | 1.87% |
| STATE STREET CORP | 11/14/2025 | 1.61 M | $12.06 M | 16.91% | 1.75% |
| CITADEL ADVISORS LLC | 11/14/2025 | 1.59 M | $11.94 M | -59.24% | 1.74% |
| NUVEEN, LLC | 11/12/2025 | 1.47 M | $11.07 M | 24.81% | 1.61% |
| DIMENSIONAL FUND ADVISORS LP | 11/12/2025 | 1.46 M | $10.94 M | -11.78% | 1.59% |
| FRANKLIN RESOURCES INC | 11/13/2025 | 1.28 M | $9.59 M | 0.01% | 1.40% |
| PICTET ASSET MANAGEMENT HOLDING SA | 11/18/2025 | 1.10 M | $8.29 M | 100.00% | 1.21% |
| UBS GROUP AG | 11/13/2025 | 972.77 K | $7.31 M | -16.97% | 1.06% |
| INTEGRAL HEALTH ASSET MANAGEMENT, LLC | 11/14/2025 | 950.00 K | $7.13 M | 35.71% | 1.04% |
| MILLENNIUM MANAGEMENT LLC | 11/14/2025 | 941.58 K | $7.07 M | -5.54% | 1.03% |
| PARKMAN HEALTHCARE PARTNERS LLC | 11/14/2025 | 934.76 K | $7.02 M | 14.30% | 1.02% |
| SUPERSTRING CAPITAL MANAGEMENT LP | 11/14/2025 | 789.65 K | $5.93 M | -38.63% | 0.86% |
| BANK OF AMERICA CORP /DE/ | 11/14/2025 | 704.77 K | $5.29 M | 42.72% | 0.77% |
| JPMORGAN CHASE & CO | 11/26/2025 | 682.71 K | $5.13 M | 90.59% | 0.75% |
| RENAISSANCE TECHNOLOGIES LLC | 11/13/2025 | 676.83 K | $5.08 M | -26.63% | 0.74% |
| NORTHERN TRUST CORP | 11/14/2025 | 587.55 K | $4.41 M | 2.94% | 0.64% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 11/10/2025 | 583.27 K | $4.38 M | 160.13% | 0.64% |
| GOLDMAN SACHS GROUP INC | 11/14/2025 | 546.83 K | $4.11 M | 67.62% | 0.60% |
| ACUTA CAPITAL PARTNERS, LLC | 11/14/2025 | 502.80 K | $3.78 M | 8.39% | 0.55% |
| INVESCO LTD. | 11/13/2025 | 477.67 K | $3.59 M | 405.29% | 0.52% |
| DEUTSCHE BANK AG\ | 11/13/2025 | 380.75 K | $2.86 M | 2.01% | 0.42% |
| SALEM INVESTMENT COUNSELORS INC | 10/07/2025 | 346.85 K | $2.60 M | 0.00% | 0.38% |
| DIADEMA PARTNERS LP | 11/14/2025 | 323.16 K | $2.43 M | 24.36% | 0.35% |
| WOODLINE PARTNERS LP | 11/14/2025 | 292.06 K | $2.19 M | -3.17% | 0.32% |
| WELLINGTON MANAGEMENT GROUP LLP | 11/14/2025 | 253.41 K | $1.90 M | -24.39% | 0.28% |
| DIADEMA PARTNERS LP | 11/14/2025 | 225.20 K | $1.69 M | 39.96% | 0.25% |
| SCHRODER INVESTMENT MANAGEMENT GROUP | 11/13/2025 | 217.93 K | $1.70 M | -42.07% | 0.24% |
| BANK OF NEW YORK MELLON CORP | 11/03/2025 | 208.18 K | $1.56 M | 2.95% | 0.23% |
| BOOTHBAY FUND MANAGEMENT, LLC | 11/14/2025 | 178.88 K | $1.34 M | 216.79% | 0.20% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2025 | 170.30 K | $1.28 M | 1,273.39% | 0.19% |
| AMERICAN CENTURY COMPANIES INC | 11/12/2025 | 165.05 K | $1.24 M | 27.28% | 0.18% |
| IKARIAN CAPITAL, LLC | 11/14/2025 | 164.20 K | $1.23 M | 180.73% | 0.18% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 11/17/2025 | 136.98 K | $1.03 M | -32.38% | 0.15% |
| SAMSARA BIOCAPITAL, LLC | 11/14/2025 | 135.57 K | $1.02 M | -33.00% | 0.15% |
| BARCLAYS PLC | 11/12/2025 | 130.39 K | $979.24 K | -46.70% | 0.14% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 11/13/2025 | 125.16 K | $939.92 K | 100.00% | 0.14% |
| JANE STREET GROUP, LLC | 11/14/2025 | 122.50 K | $919.98 K | 100.00% | 0.13% |
| EXCHANGE TRADED CONCEPTS, LLC | 10/14/2025 | 121.46 K | $912.13 K | -46.69% | 0.13% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Terns Pharmaceuticals, Inc. institutional Ownership - FAQ's
During the previous two years, 171 institutional investors and hedge funds held shares of Terns Pharmaceuticals, Inc.. The most heavily invested institutionals were:
Soleus Capital Management, L.P.: 8.13 M
MORGAN STANLEY: 7.59 M
ORBIMED ADVISORS LLC: 7.56 M
Deep Track Capital, LP: 7.5 M
Vivo Capital, LLC: 6.9 M
COMMODORE CAPITAL LP: 5.7 M
96.80% of Terns Pharmaceuticals, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 96.96 M shares in the last 24 months. This purchase volume represents approximately $797.98 M in transactions.